Compassionate Certification Centers at the Forefront of Medical Cannabis Research in Pennsylvania

PITTSBURGH, Feb. 11, 2019 /PRNewswire-PRWeb/ -- Compassionate Certification Centers™, a U.S. medical cannabis healthcare system, today announced it plans to expand research endeavors to include more hemp-derived cannabidiol (CBD) studies following the legalization of hemp under the 2018 U.S. Farm Bill.

Dr. Bryan Doner, co-founder and Chief Medical Officer at Compassionate Certification Centers, is currently leading the first clinical research study on Irritable Bowel Syndrome (IBS) and CBD. In partnership with clinical research organization Affinity Bio Partners, Doner was selected by SciCann Therapeutics and FSD Pharma for the project.

Clinical research enrollment is expected to take place this February and will be comprised of 20 subjects, which could increase during the three-month trial. The pioneering study will look into the therapeutic benefits of the cannabis plant utilizing the CannaBot™ a cutting-edge artificial intelligence bot from AI Health Outcomes.

In addition, Doner and Compassionate Certification Centers plan to partner with a Pennsylvania university or medical school to do additional research in state, as well as internationally in South America and Europe.

"We are focused on combining cannabis-based therapy with other treatment modalities to get a better understanding of potential treatment synergies for specific conditions," stated Doner.

Compassionate Certification Centers provides CBD and medical cannabis evaluations and certifications at locations throughout Pennsylvania. The company has its own line of THC-free CBD products, available to patients and non-cardholders. In July 2019, Compassionate Certification Centers will host its 3rd Annual World Medical Cannabis Conference & Expo in Philadelphia. For more information visit cccregister.com.

About Compassionate Certification Centers®

Compassionate Certification Centers is the first United States Medical Cannabis Healthcare System, specializing in cannabis medicine. The company is devoted to assisting U.S. citizens discover medical cannabis treatment options in a way that respects the laws of each state with proof of compliance for the respective governing agencies.

Compassionate Certification Centers employs a team of medical cannabis doctors from different specialties who inform, educate, and guide patients on how to obtain a Medical Card and different treatment options to potentially improve quality of life. Its network of convenient healthcare centers offers CBD and THC consultation and care, as well as a full spectrum of CBD products to purchase onsite or online. Compassionate Certification Centers provides a patient-friendly experience in a comfortable and supportive environment. The organization is able to operate its centers with a retail component in every medical region in the country.

Compassionate Certification Centers is involved in expanding medical cannabis education and is currently conducting a clinical trial on CBD. The organization annually hosts the World Medical Cannabis Conference & Expo, a multi-day event that features industry experts in the fields of business, science, medicine, technology, policy, and more. For information, visit compassionatecertificationcenters.com or join the discussion at Facebook, Twitter, LinkedIn, Instagram and Google+.

SOURCE Compassionate Certification Centers